CRVS Corvus Pharmaceuticals, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
03:33
Aug 21
seedy19tron
Short CRVS on enrolment games
Short CRVS because the company played games with enrollment, undermining its trial data; the speaker sees it as an easier short than KYMR.
CRVS Corvus Pharmaceuticals, Inc. Short 3RD — —
13:13
Jun 21
seedy19tron
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A.
Buy the "hot zone" biotech names (3–9 months post positive data) as the author's historical M&A timing framework shows this is the window where acquirers with pre-committed capital execute; sector M&A wave across radiopharmaceuticals, MASH, IBD, and obesity validates the pattern is active.
CRVS Corvus Pharmaceuticals, Inc. Long — —
15:02
Jun 19
seedy19tron
Buy CRVS ahead of Monday open; author sees novel mechanism undervaluation in the AtD space.
Buy CRVS ahead of Monday open; author sees novel mechanism undervaluation in the AtD space versus perceived winner $APGE, expecting a sharp re-rating catalyst at the open.
CRVS Corvus Pharmaceuticals, Inc. Long 2ND — —
Log in to see ideas

About CRVS Investor Commentary

Across the available history and selected sources, Buzzberg tracks CRVS (Corvus Pharmaceuticals, Inc.) across 3 sources: 3 bullish vs 7 bearish calls from 3 authors. Historical directional balance: -16% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 25 total trade ideas tracked. Latest voices: seedy19tron.